Paper35686268
An Update to Hallmarks of Cancer.
Ravi S and 8 others. Cureus, 2022. Cited by 24 papers, by iCite.
Cite this record
ConductScience Library. An Update to Hallmarks of Cancer. Papers, record 35686268. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/35686268
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics0
NLM's MeSH indexing of the paper, its major topics first.
None in this release.
References171
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 27323951 | Roles of telomeres and telomerase in cancer, and advances in telomerase-targeted therapies. | Genome Med | 2016 | https://conductscience.org/library/papers/27323951 | PubMed |
| 2 | 22685290 | Elevation of highly up-regulated in liver cancer (HULC) by hepatitis B virus X protein promotes hepatoma cell proliferation via down-regulating p18. | J Biol Chem | 2012 | https://conductscience.org/library/papers/22685290 | PubMed |
| 3 | 26852748 | Autophagy regulates resistance of non-small cell lung cancer cells to paclitaxel. | Tumour Biol | 2016 | https://conductscience.org/library/papers/26852748 | PubMed |
| 4 | 19711245 | Epigenetics: definition, mechanisms and clinical perspective. | Semin Reprod Med | 2009 | https://conductscience.org/library/papers/19711245 | PubMed |
| 5 | 30914826 | Navigating metabolic pathways to enhance antitumour immunity and immunotherapy. | Nat Rev Clin Oncol | 2019 | https://conductscience.org/library/papers/30914826 | PubMed |
| 6 | 23967302 | Expression of galectin-7 is induced in breast cancer cells by mutant p53. | PLoS One | 2013 | https://conductscience.org/library/papers/23967302 | PubMed |
| 7 | 9039261 | Programmed cell death in animal development. | Cell | 1997 | https://conductscience.org/library/papers/9039261 | PubMed |
| 8 | 32025013 | The evolutionary history of 2,658 cancers. | Nature | 2020 | https://conductscience.org/library/papers/32025013 | PubMed |
| 9 | 23348506 | Highly recurrent TERT promoter mutations in human melanoma. | Science | 2013 | https://conductscience.org/library/papers/23348506 | PubMed |
| 10 | 19208461 | ErbB receptors and signaling pathways in cancer. | Curr Opin Cell Biol | 2009 | https://conductscience.org/library/papers/19208461 | PubMed |
| 11 | 17322878 | A module of negative feedback regulators defines growth factor signaling. | Nat Genet | 2007 | https://conductscience.org/library/papers/17322878 | PubMed |
| 12 | 17627278 | Regulation of the p27(Kip1) tumor suppressor by miR-221 and miR-222 promotes cancer cell proliferation. | EMBO J | 2007 | https://conductscience.org/library/papers/17627278 | PubMed |
| 13 | 14603257 | DNA-damaging reagents induce apoptosis through reactive oxygen species-dependent Fas aggregation. | Oncogene | 2003 | https://conductscience.org/library/papers/14603257 | PubMed |
| 14 | 30696923 | Immune control by amino acid catabolism during tumorigenesis and therapy. | Nat Rev Cancer | 2019 | https://conductscience.org/library/papers/30696923 | PubMed |
| 15 | 23342266 | Coordinate regulation between expression levels of telomere-binding proteins and telomere length in breast carcinomas. | Cancer Med | 2012 | https://conductscience.org/library/papers/23342266 | PubMed |
| 16 | 24585095 | Spautin-1, a novel autophagy inhibitor, enhances imatinib-induced apoptosis in chronic myeloid leukemia. | Int J Oncol | 2014 | https://conductscience.org/library/papers/24585095 | PubMed |
| 17 | 21709020 | PERK integrates autophagy and oxidative stress responses to promote survival during extracellular matrix detachment. | Mol Cell Biol | 2011 | https://conductscience.org/library/papers/21709020 | PubMed |
| 18 | 21127245 | Autophagy and metabolism. | Science | 2010 | https://conductscience.org/library/papers/21127245 | PubMed |
| 19 | 28754961 | The Maintenance of Telomere Length in CD28+ T Cells During T Lymphocyte Stimulation. | Sci Rep | 2017 | https://conductscience.org/library/papers/28754961 | PubMed |
| 20 | 28635679 | The Role of Angiogenesis in Cancer Treatment. | Biomedicines | 2017 | https://conductscience.org/library/papers/28635679 | PubMed |
Cited by20
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 24 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42963104 | Epigenetic targeting of an HBO1-H3K9la-CHI3L1 axis reduces regulatory B cell-mediated CD8+ T cell dysfunction in lung adenocarcinoma. | J Immunother Cancer | 2026 | https://conductscience.org/library/papers/42963104 | PubMed |
| 42093974 | Integrated single-cell and bulk transcriptomics identify autophagy-related immune-suppressive subtypes and a prognostic signature in colorectal cancer. | Front Immunol | 2026 | https://conductscience.org/library/papers/42093974 | PubMed |
| 42022329 | Piperine as a modulator of cancer hallmarks: mechanistic insights and therapeutic potential. | Front Oncol | 2026 | https://conductscience.org/library/papers/42022329 | PubMed |
| 41899410 | Genistein-Butein Co-Treatment Suppresses Glycolytic Metabolism and Induces Apoptotic Signaling in PC-3 Prostate Cancer Cells. | Curr Issues Mol Biol | 2026 | https://conductscience.org/library/papers/41899410 | PubMed |
| 41896223 | Targeting glioblastoma mitochondrial metabolism with S-Gboxin induces cytotoxicity under conditions of the tumor microenvironment. | Cell Death Discov | 2026 | https://conductscience.org/library/papers/41896223 | PubMed |
| 41341180 | Expression of PPAR-alpha and gamma in breast cancer patients and their relationship with the expression of FASN, ACSL4, and ACLY genes. | Res Pharm Sci | 2025 | https://conductscience.org/library/papers/41341180 | PubMed |
| 40725141 | Nature-Inspired Strategies in Cancer Management: The Potential of Plant Extracts in Modulating Tumour Biology. | Int J Mol Sci | 2025 | https://conductscience.org/library/papers/40725141 | PubMed |
| 40594369 | Feasibility of long-read sequencing to identify molecular alterations in an Indonesian cohort of locally advanced to advanced nasopharyngeal cancer. | Sci Rep | 2025 | https://conductscience.org/library/papers/40594369 | PubMed |
| 39956859 | Molecular principles underlying aggressive cancers. | Signal Transduct Target Ther | 2025 | https://conductscience.org/library/papers/39956859 | PubMed |
| 39901548 | Advances in Synthetic Lethality in Potential Oncology Therapeutic Approaches. | Curr Top Med Chem | 2025 | https://conductscience.org/library/papers/39901548 | PubMed |
| 39862360 | Telomerase in cancer- ongoing quest and future discoveries. | Mol Biol Rep | 2025 | https://conductscience.org/library/papers/39862360 | PubMed |
| 39841384 | Cancer and Secretomes: HLA-G and Cancer Puzzle. | Adv Exp Med Biol | 2025 | https://conductscience.org/library/papers/39841384 | PubMed |
| 39725785 | Recapitulating the potential contribution of protein S-palmitoylation in cancer. | Cancer Metastasis Rev | 2024 | https://conductscience.org/library/papers/39725785 | PubMed |
| 39457512 | Multifaceted Properties of Usnic Acid in Disrupting Cancer Hallmarks. | Biomedicines | 2024 | https://conductscience.org/library/papers/39457512 | PubMed |
| 39272454 | Targeting Cancer Hallmarks Using Selected Food Bioactive Compounds: Potentials for Preventive and Therapeutic Strategies. | Foods | 2024 | https://conductscience.org/library/papers/39272454 | PubMed |
| 38248644 | New Rare Triterpene Glycosides from Pacific Sun Star, Solaster pacificus, and Their Anticancer Activity. | Mar Drugs | 2023 | https://conductscience.org/library/papers/38248644 | PubMed |
| 37749560 | Ginsenosides: changing the basic hallmarks of cancer cells to achieve the purpose of treating breast cancer. | Chin Med | 2023 | https://conductscience.org/library/papers/37749560 | PubMed |
| 37371804 | Insights on the Role of Polyphenols in Combating Cancer Drug Resistance. | Biomedicines | 2023 | https://conductscience.org/library/papers/37371804 | PubMed |
| 37367892 | The Metabolism and Immune Environment in Diffuse Large B-Cell Lymphoma. | Metabolites | 2023 | https://conductscience.org/library/papers/37367892 | PubMed |
| 36422095 | A Pan-Cancer Atlas of Differentially Interacting Hallmarks of Cancer Proteins. | J Pers Med | 2022 | https://conductscience.org/library/papers/36422095 | PubMed |
Genes75
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/35686268
GET https://conductscience.org/api/papers/v1/35686268/references?page=2